Neurocrine Biosciences Inc. Earnings

Neurocrine Biosciences Inc.’s revenue jumped 21.84% since last year same period to $627.7Mn in the Q4 2024. On a quarterly growth basis, Neurocrine Biosciences Inc. has generated 0.9% jump in its revenue since last 3-months.

Neurocrine Biosciences Inc.’s net profit fell -30.2% since last year same period to $103.1Mn in the Q4 2024. On a quarterly growth basis, Neurocrine Biosciences Inc. has generated -20.57% fall in its net profits since last 3-months.

Neurocrine Biosciences Inc.’s net profit margin fell -42.71% since last year same period to 16.43% in the Q4 2024. On a quarterly growth basis, Neurocrine Biosciences Inc. has generated -21.28% fall in its net profit margins since last 3-months.

Neurocrine Biosciences Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.93 - a 27.78% jump from last quarter’s estimates.

Neurocrine Biosciences Inc.’s earning per share (EPS) estimates for the current year stand at 1.93.

Neurocrine Biosciences Inc.’s earning per share (EPS) jumped 17.36% since last year same period to 1.69 in the Q4 2024. This indicates that the Neurocrine Biosciences Inc. has generated 17.36% annual rate of jump in its earning per share (EPS) in the last 4 quarters.